Literature DB >> 19422455

Results of a worldwide survey on the assessment of platelet function by light transmission aggregometry: a report from the platelet physiology subcommittee of the SSC of the ISTH.

M Cattaneo1, C P M Hayward, K A Moffat, M T Pugliano, Y Liu, A D Michelson.   

Abstract

BACKGROUND: Light transmission aggregometry (LTA) is the most common method used in clinical and research laboratories to assess platelet function. However, the method has never been standardized.
OBJECTIVES: As the first step towards development of methodological guidelines, the Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis (ISTH) undertook a large, detailed, global survey of LTA practices.
METHODS: Members of ISTH and of External Quality Assurance in Thrombosis and Haemostasis organizations were invited to complete a 129 item, online questionnaire. Results were analyzed anonymously to participant identities.
RESULTS: The online supplement for this article (http://www.isth.org/Publications/OfficialCommunications/PlateletPhysiology/LightTransmissionAggregometry/tabid/201/Default.aspx) contains the full details of the study findings. 359 (244 clinical, 115 research) laboratories from 48 countries participated in the survey. LTA was widely used to assess inherited or acquired bleeding disorders. Common practices were identified in sample collection, processing and analysis and although some are generally considered acceptable, others are not ideal. The agonist concentrations used for LTA varied, and many laboratories used ADP, collagen, epinephrine and Ristocetin, at more than one concentration, in addition to arachidonic acid. The parameters commonly used to assess LTA responses were maximal amplitude or % aggregation, which was considered particularly important, in addition to the presence of a 'secondary wave', deaggregation, shape change and a measure of the lag phase. However, many laboratories did not have appropriate reference intervals.
CONCLUSIONS: This is the largest and most detailed survey of LTA practices ever undertaken. It shows a very high variability in LTA practices worldwide, and, as a consequence, methodological standardization is necessary. The information gathered in this survey will be helpful in the development of ISTH methodological guidelines for LTA.

Entities:  

Mesh:

Year:  2009        PMID: 19422455     DOI: 10.1111/j.1538-7836.2009.03458.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  28 in total

1.  Evaluating platelet aggregation dynamics from laser speckle fluctuations.

Authors:  Zeinab Hajjarian; Diane M Tshikudi; Seemantini K Nadkarni
Journal:  Biomed Opt Express       Date:  2017-06-30       Impact factor: 3.732

2.  Single ascending oral dose pharmacokinetics and pharmacodynamics study of EV-077: the specific inhibitor of prostanoid- and isoprostane-induced cellular activation.

Authors:  A Richardson; K S Sakariassen; J-P Meyer; P Alberts; A S Sorensen
Journal:  Eur J Clin Pharmacol       Date:  2012-07-20       Impact factor: 2.953

Review 3.  Monitoring the effectiveness of antiplatelet therapy: opportunities and limitations.

Authors:  Nalyaka Sambu; Nick Curzen
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335

4.  Strategies in Clinical and Laboratory Diagnosis of Inherited Platelet Function Disorders in Children.

Authors:  Ralf Knöfler; Werner Streif
Journal:  Transfus Med Hemother       Date:  2010-09-15       Impact factor: 3.747

5.  Centrifugation speed affects light transmission aggregometry.

Authors:  M Merolla; M A Nardi; J S Berger
Journal:  Int J Lab Hematol       Date:  2011-07-27       Impact factor: 2.877

Review 6.  Clinical pharmacokinetics and pharmacodynamics of clopidogrel.

Authors:  Xi-Ling Jiang; Snehal Samant; Lawrence J Lesko; Stephan Schmidt
Journal:  Clin Pharmacokinet       Date:  2015-02       Impact factor: 6.447

Review 7.  Monitoring aspirin and clopidogrel response: testing controversies and recommendations.

Authors:  Athanasios Karathanos; Tobias Geisler
Journal:  Mol Diagn Ther       Date:  2013-06       Impact factor: 4.074

8.  Microengineered Human Vein-Chip Recreates Venous Valve Architecture and Its Contribution to Thrombosis.

Authors:  Navaneeth Krishna Rajeeva Pandian; Brandon K Walther; Rishi Suresh; John P Cooke; Abhishek Jain
Journal:  Small       Date:  2020-11-17       Impact factor: 13.281

9.  Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel.

Authors:  Ban B Dawood; Gillian C Lowe; Marie Lordkipanidzé; Danai Bem; Martina E Daly; Mike Makris; Andrew Mumford; Jonathan T Wilde; Steve P Watson
Journal:  Blood       Date:  2012-09-21       Impact factor: 22.113

10.  A novel thromboxane A2 receptor D304N variant that abrogates ligand binding in a patient with a bleeding diathesis.

Authors:  Andrew D Mumford; Ban B Dawood; Martina E Daly; Sherina L Murden; Michael D Williams; Majd B Protty; Jennifer C Spalton; Mark Wheatley; Stuart J Mundell; Steve P Watson
Journal:  Blood       Date:  2009-10-14       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.